Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

CV Therapeutics seeks permission to move CVT-510 to clinical trials

Jan. 20, 1998

Cardizem Monovial now available in U.S.

Jan. 19, 1998

Novartis reveals agents for atherosclerosis and chronic inflammation

Jan. 19, 1998

Inhibition of monocyte-endothelial cell adhesion in atherogenesis by anti-CD43 MAb

Jan. 16, 1998

BASF reports new endothelin antagonists

Jan. 16, 1998

Compounds for cardiovascular diseases described by BMS

Jan. 16, 1998

Phase III trials of Natrecor BNP now successfully completed

Jan. 15, 1998

FDA clears new indication for Rythmol

Jan. 15, 1998

Kyowa Hakko characterizes new MLCK inhibitors from soil fungus

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...